Status:
COMPLETED
Allo SCT in Amyloidosis Non-interventional Study
Lead Sponsor:
European Society for Blood and Marrow Transplantation
Conditions:
AL Amyloidosis
Eligibility:
All Genders
18-60 years
Brief Summary
Light-chain (AL-) amyloidosis is a very rare monoclonal plasma cell disorder with poor prognosis. Rarity of disease has precluded performance of randomized controlled trials comparing various possible...
Detailed Description
Short description of the study: We plan to select those centres within the EBMT that in the past have performed any allogeneic transplant for amyloidosis and ask them to participate by completing a c...
Eligibility Criteria
Inclusion
- AL Amyloidosis, allogeneic HSCT after November 2009, between 18-60 years at time of transplant.
Exclusion
- other diagnoses than AL Amyloidosis, auto transplant, transplant before November 2009, younger than 18 or older than 60 at time of transplant.
Key Trial Info
Start Date :
December 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT02257905
Start Date
December 1 2009
Last Update
July 24 2015
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Limoges
Limoges, France
2
University Hospital Eppendorf
Hamburg, Germany
3
University of Heidelberg
Heidelberg, Germany
4
University Hospital
Basel, Switzerland